You are here
Improved Formulations to Enhance Bio-availability for Antisense Therapeutics
Title: Chief Technology Officers
Phone: (630) 854-8173
Email: luisteo@aol.com
Title: CEO
Phone: (402) 416-1811
Email: lnkchemsolutions@aim.com
In general, many biological and chemical agents affect the lungs directly or indirectly, even if the respiratory system is not the primary target organ of a military or terrorist attack. Both in the case of military and civilian attacks the lung can be one of the first organs affected by a chemical or biological agent. LNK Chemsolutions (LNK) with expertise in nanoparticle formulations and the University of Illinois Chicago with expertise in Acute Lung Injury (ALI) molecular biology and treatment modality development have teamed up to develop novel oral and inhalation formulation of targeted nanoparticles (NPs) containing siRNA and/or miRNA to improve the treatment of ALI unobtainable with current delivery systems.
* Information listed above is at the time of submission. *